Systems Biology of Cancer: which pathways to choose? Emmanuel Barillot



Similar documents
Understanding the dynamics and function of cellular networks

Protein Protein Interaction Networks

Bioinformatics: Network Analysis

Normal values of IGF1 and IGFBP3. Kučera R., Vrzalová J., Fuchsová R., Topolčan O., Tichopád A.

Healthcare Analytics. Aryya Gangopadhyay UMBC

Mathematical Models of Supervised Learning and their Application to Medical Diagnosis

Exercises for the UCSC Genome Browser Introduction

Using Ontologies in Proteus for Modeling Data Mining Analysis of Proteomics Experiments

Guide for Data Visualization and Analysis using ACSN

Comparison of Non-linear Dimensionality Reduction Techniques for Classification with Gene Expression Microarray Data

Lesson 3 Reading Material: Oncogenes and Tumor Suppressor Genes

ProteinQuest user guide

CONTRACTING ORGANIZATION: University of Alabama at Birmingham Birmingham, AL 35294

AADL et la conception des logiciels

Genomic Medicine The Future of Cancer Care. Shayma Master Kazmi, M.D. Medical Oncology/Hematology Cancer Treatment Centers of America

Enterprise Risk Management & Board members. GUBERNA Alumni Event June 19 th 2014 Prepared by Gaëtan LEFEVRE

Visualizing Networks: Cytoscape. Prat Thiru

The National Institute of Genomic Medicine (INMEGEN) was

Department of BioScience Technology Chung Yuan Christian University 2015/08/13

Linux A multi-purpose executive support for civil avionics applications?

Feed Forward Loops in Biological Systems

Analysis of the colorectal tumor microenvironment using integrative bioinformatic tools

Vad är bioinformatik och varför behöver vi det i vården? a bioinformatician's perspectives

Targeted Therapy What the Surgeon Needs to Know

Sommaire projets sélectionnés mesure 29: Soutien à la recherche translationnelle

High Throughput Network Analysis

Managing the Knowledge Exchange between the Partners of the Supply Chain

1. Introduction Gene regulation Genomics and genome analyses Hidden markov model (HMM)

AP Biology Essential Knowledge Student Diagnostic

BIOINF 525 Winter 2016 Foundations of Bioinformatics and Systems Biology

Update in Hematology Oncology Targeted Therapies. Mark Holguin

Un (bref) aperçu des méthodes et outils de fouilles et de visualisation de données «omics»

Bioinformatics Grid - Enabled Tools For Biologists.

Centre International de Hautes Etudes Agronomiques MÄditerranÄennes. International Centre for Advanced Mediterranean Agronomic Studies POINT 9

TUTORING IN DISTANCE EDUCATION

HCERES report on research unit:

Wissenschaftliche Highlights der GSF 2007

Cancer SBL101. James Gomes School of Biological Sciences Indian Institute of Technology Delhi

In developmental genomic regulatory interactions among genes, encoding transcription factors

Unraveling protein networks with Power Graph Analysis

Data Mining and Machine Learning in Bioinformatics

Course on Functional Analysis. ::: Gene Set Enrichment Analysis - GSEA -

Cancer Clinical Trials: In-Depth Information

A brief introduction to Cytoscape

micrornas Non protein coding, endogenous RNAs of 21-22nt length Evolutionarily conserved

LCFA/IASLC LORI MONROE SCHOLARSHIP IN TRANSLATIONAL LUNG CANCER RESEARCH

Genetomic Promototypes

Data Integration. Lectures 16 & 17. ECS289A, WQ03, Filkov

Technology funding opportunities at the National Cancer Institute

MUTATION, DNA REPAIR AND CANCER

BEYKOZ-E Reg. Owner: BV Reg. Nr: IMO Number: Vessel Type: Gross Tonnage: Date of build:

La Protéomique : Etat de l art et perspectives

Report series: General cancer information

Medical Informatics II

Personnalisez votre intérieur avec les revêtements imprimés ALYOS design

Master's projects at ITMO University. Daniil Chivilikhin PhD ITMO University

Controller design for climate control in buildings using CLIM 2000

The Making of the Fittest: Evolving Switches, Evolving Bodies

Contents. molecular biology techniques. - Mutations in Factor II. - Mutations in MTHFR gene. - Breast cencer genes. - p53 and breast cancer

2019 Healthcare That Works for All

PART 3.3: MicroRNA and Cancer

French Property Registering System: Evolution to a Numeric Format?

Year 10: The transmission of heritable characteristics from one generation to the next involves DNA

Operation Structure (OS)

Big data in cancer research : DNA sequencing and personalised medicine

Graphical Modeling for Genomic Data

FlipFlop: Fast Lasso-based Isoform Prediction as a Flow Problem

Functional Data Analysis of MALDI TOF Protein Spectra

A Comparison of BEL V1.0 and BioPAX Level 3

RESEARCH EDUCATE ADVOCATE. Just Diagnosed with Melanoma Now What?

Archived Content. Contenu archivé

Regulation of Protein Translation and c-jun expression by Prostate Tumor Overexpressed1 (PTOV1)

Network Analysis. BCH 5101: Analysis of -Omics Data 1/34

BAP1 germline mutations A new Cutaneous Nevus Melanoma Syndrome. Thomas Wiesner

The SAMANTA platform. Emeritus Expert SNECMA. Department Prognostic Health Monitoring Systems SNECMA

Program'! Governance)Innovation)Lecture)Series) )Cycle)de)conférence)Innovations)en)gouvernance)

Immunotherapy of Uveal Melanoma

Identification of rheumatoid arthritis and osteoarthritis patients by transcriptome-based rule set generation

LESSON 3.5 WORKBOOK. How do cancer cells evolve? Workbook Lesson 3.5

NBC MANAGEMENT ACTION PLAN PLAN D ACTION DE CCBN

Hardware and software requirements of CB monitoring and POW relays: benefits of an integration of functions

Towards a galaxy.prabi.fr

Neural Networks Tools for Improving Tacite Hydrodynamic Simulation of Multiphase Flow Behavior in Pipelines

Molekylært målrettet medicinsk kræftbehandling for klinikere principper og metoder

Leukemia Drug Pathway Analyzer

RETRIEVING SEQUENCE INFORMATION. Nucleotide sequence databases. Database search. Sequence alignment and comparison

Etudes de cas en OCL avec l outil USE 2

White Paper. Yeast Systems Biology - Concepts

BSc (Hons) Biology (Minor: Forensic Science or Marine & Coastal Environmental Science)/MSc Biology SC516 (Subject to Approval) SC516

Transcription:

Systems Biology of Cancer: which pathways to choose? Emmanuel Barillot

Central questions to cancer On the clinical side: predict the phenotype On the biological side: explain tumorigenesis and tumoral progression Classification of tumors (diagnosis and prognosis) based on molecular profiles

The case of uveal melanoma Clustering on 86 ocular tumors, based on molecular profiles : Legend : Blue chr3 monosomy - Red chr3 disomy Purple non-metastasis - Green metastasis Detection of few recurrent alterations + Clustering Groups and metastasis : L1p, L3, G8q : 56% metastasis L3, G8q : 72% metastasis L1p, L3, G8q L1p L3 : 12,5% metastasis L3 G6p, G8q : 40% metastasis G6p : 14% metastasis Classification achieves 75% L3, G8q L3 G8q sensibility and 75% specificity. G6p, G8q G8q G6p G6p 3

Central questions to cancer On the clinical side: predict the phenotype «small n, large p» (JP Vert talk this morning) Not all answers can be predicted Is there a treatment? On the biological side: explain tumorigenesis and tumoral progression Identify pathways Understand their principles Model their effect on the phenotype

Systems Biology: statistical vs mechanistical models perturbation perturbation

Systems Biology Génomique, post-génomique et biologie des systèmes Les propriétés émergentes d un système complexe sont irréductibles à celles de ses composants La fonction n est pas accessible à l étude spécifique d un élément Jeux de données exhaustifs, multi-échelles, issus des nouvelles technologies de biologie à haut débit : Génome, transcriptome, protéome, interactome, phénotypes cellulaires

Biologie des Systèmes du Cancer Modélisation des voies de régulation associées au cancer: Structure : littérature et inférence depuis les données Dynamique : modèles quantitatifs et qualitatifs Contrôle : effet des perturbations Allers-retours entre modèles et expériences?? not observable?? + - -?? + -????? - - - - -? + + +? + +??? negative deviations Perturbation

Objective of the Systems Biology of Cancer Group Use available information of molecular structures and interactions and integration of heterogeneous multi-level sources of data for creating mechanistical and statistical models of human cancer with the aim to contribute to the prevention, diagnosis and treatment of cancer http://bioinfo.curie.fr/sysbio

Outline Building a comprehensive map of the Rb pathway from the literature Investigating the pathway modular decomposition Studying complexity and robustness of pathways (example of NFkB) Reverse-engineering and modelling of an oncogenic process in Ewing tumors Modelling qualitatively pathways for identifying intervention points Studying the evolution of network motifs

Problem-oriented and support projects Studying concrete cancers: EWING, bladder, breast Pathway modeling in the cancer context: RB, IGF, Wnt, NfκB Developing methodology: Reverse engineering, Model reduction, Qualitative modeling, Standards Software development: BiNoM (Cytoscape platform), NETI

RB-pathway structural analysis collaboration with: François Radvanyi, Institut Curie/CNRS UMR144

Comprehensive map and model of RB-pathway Detailed view, closer to reality Text book view Signal Mitogénique Cyc D CDK4/6 RB RB -P CKI (p16) E2F Progression du Cycle Cellulaire

Comprehensive map and model of RB-pathway Created with CellDesigner 3.2 (Kitano s graphical notation system) Contains 84 distinct proteins 127 genes 337 species (complexes, protein forms, ) 436 reactions (binding, modifications, regulations, ) Compiles information from 245 publications Progression du Cycle Cellulaire Creation of RB-pathway is supported by ESBIC-D European project (FP6 CA)

CellDesigner process diagrams

Structural organization of the network Methods: 1) Decomposition into independent cycles 2) Finding conservation laws from the stoichiometry matrix 3) Block-decomposition of the stoichiometry matrix

In- and Out- digraph layers External world Non-trivial network part In-layer Cyclic part (Strongly connected components) Out-layer Boundary Conditions (we can not infer the behavior of the nodes with no incoming edges) Network Output (The nodes with no outcoming edges do not have effect on the rest of the network)